Amifampridine
Ruzurgi, Firdapse, Zenas (amifampridine) is a small molecule pharmaceutical. Amifampridine was first approved as Ruzurgi on 2009-12-23. It is used to treat lambert-eaton myasthenic syndrome in the USA. It has been approved in Europe to treat lambert-eaton myasthenic syndrome.
| Trade Name | Firdapse, Zenas |
|---|---|
| Common Name | Amifampridine |
| Indication | lambert-eaton myasthenic syndrome |
| Drug Class |
